Skip to content

Effect of different times of percutaneous acupoint electrical stimulation on immune function of patients undergoing thoracoscopic radical treatment for lung cancer

Effect of different times of percutaneous acupoint electrical stimulation on immune function of patients undergoing thoracoscopic radical treatment for lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000825
Enrollment
Unknown
Registered
2024-12-15
Start date
2024-12-24
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

B group:Stimulation 30min after surgery
T group:Stimulation before induction of anesthesia for 30 min until the end of surgery group
A group:Stimulation 30min before induction of anesthesia

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: We carried out the effects of different timing of transcutaneous electrical acupoint stimulation on the immune function of patients undergoing radical treatment of thoracoscopic lung cancer in order to address the following questions: 1 whether TEAS affects the immune function of patients undergoing radical treatment of thoracoscopic lung cancer; 2 whether different timing of TEAS affects the immune function of patients undergoing radical treatment of thoracoscopic lung cancer differently. This will provide a reference basis for choosing the optimal stimulation timing for TEAS in clinical practice.

Exclusion criteria

Exclusion criteria: Severe cardiopulmonary hepatic and renal dysfunction; those with skin lesions on the extremities; those who have had radiation or chemotherapy in the last month radiotherapy or chemotherapy; long-term use of immunosuppressants

Design outcomes

Primary

MeasureTime frame
NK cells count;T lymphocytes count;

Secondary

MeasureTime frame
Postoperative sufentanil dosage;Postoperative eye opening extubation recovery time of orientation and duration of stay in the recovery room;Postoperative VAS score;opioid use;heard rate blood pressure;vasoactive drug dosage;Propofol dosage;Postoperative nausea and vomiting incidence rate;

Countries

China

Contacts

Public ContactYe Ling

The First Affiliated Hospital of Zhejiang Chinese Medicine University

2404893787@qq.com+86 135 1681 8925

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026